|
Siemens Healthcare Diagnostics, Inc.
|
|
|
|
Enhancing the Siemens Healthcare Diagnostics leadership position in cardiac markers and enriching an already comprehensive cardiac disease state panel that includes cardiac troponin I, hsCRP and myoglobin, the NT-proBNP assay is used to risk stratify patients with Acute Coronary Syndromes (ACS) and Congestive Heart Failure (CHF), and is also an aid in diagnosing CHF. Now you have even more of a reason to select Siemens for your total cardiac solution.
|